Metal protein attenuating compounds for the treatment of Alzheimer's dementia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metal protein attenuating compounds for the treatment of Alzheimer's dementia

Published:2014-02-21 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sampson Elizabeth L¹,Jenagaratnam Lydia²,McShane Rupert³

Affiliation:

1. University College; Marie Curie Palliative Care Research Unit; 67-73 Riding House Street London UK W1W 7EJ

2. Churchill Hospital; The Fulbrook Centre; Headington Oxford UK OX3 7JU

3. University of Oxford; Radcliffe Department of Medicine; John Radcliffe Hospital Level 4, Main Hospital, Room 4401C Oxford Oxfordshire UK OX3 9DU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference27 articles.

1. Safety, efficacy and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa double-blind randomised placebo-controlled trial;Lannfelt;Lancet Neurology,2008

2. Metal-protein attenuation with iodo-chlorhroxyquin(clioquinol) targeting Aß amyloid deposition and toxicity in Alzheimer disease:a pilot phase 2 clinical trial;Ritchie;Archives of Neurology,2003

3. Current status of metals as therapeutic targets in Alzheimer's disease;Finefrock;Journal of the American Geriatrics Society,2003

4. Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?;Mastwyk;International Psychogeriatrics IPA,2003

5. Treatment of Alzheimer's disease with clioquinol;Regland;Dementia and Geriatric Cognitive Disorders,2001

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation Cu(II) selective peptide shuttles prevent Cu(Aβ)-induced toxicity and microglial activation in organotypic hippocampal slices;2024-09-08

2. Neuroprotective efficiency of celecoxib vesicular bilosomes for the management of lipopolysaccharide-induced Alzheimer in mice employing 23 full factorial design;Inflammopharmacology;2024-07-17

3. Current understanding of Alzheimer's disease;Bulletin of Integrative Psychiatry;2024-06-15

4. Application of CRISPR/Cas9 System in the Treatment of Alzheimer’s Disease and Neurodegenerative Diseases;Molecular Neurobiology;2024-04-19

5. Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity;Coordination Chemistry Reviews;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3